Moderna shares rise on planned Nasdaq 100 entry

By Reuters News

** Moderna MRNA.O shares climb 2.2% to $193.01 premarket after Nasdaq said the vaccine maker will replace media firm Warner Bros Discovery WBD.O on the Nasdaq 100 .NDX

** Change takes effect on Oct 9; inclusion in major indexes often leads to buying from passively managed funds that track the index

** As of last close, MRNA up 540.7% YTD, far outpacing the S&P 500's about 12% rise

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk